Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

Popular weight-loss drugs like Ozempic and Zepbound have revolutionized how we tackle obesity. But now, emerging reports ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...